GALECTIN THERAPEUTICS INC - FORM 10-K - EX-21.1 - SUBSIDIARIES OF PRO PHARMACEUTICALS, INC. - March 15, 2011

Attached files

file filename
10-K - FORM 10-K - GALECTIN THERAPEUTICS INCd10k.htm
EX-23.1 - CONSENT OF MCGLADREY & PULLEN, LLP - GALECTIN THERAPEUTICS INCdex231.htm
EX-31.2 - CERTIFICATION OF CFO PURSUANT TO SECTION 302 - GALECTIN THERAPEUTICS INCdex312.htm
EX-32.1 - CERTIFICATION OF CEO AND PRESIDENT PURSUANT TO SECTION 906 - GALECTIN THERAPEUTICS INCdex321.htm
EX-32.2 - CERTIFICATION OF CFO PURSUANT TO SECTION 906 - GALECTIN THERAPEUTICS INCdex322.htm
EX-23.2 - CONSENT OF CATURANO AND COMPANY, INC. - GALECTIN THERAPEUTICS INCdex232.htm
EX-31.1 - CERTIFICATION OF CEO AND PRESIDENT PURSUANT TO SECTION 302 - GALECTIN THERAPEUTICS INCdex311.htm

Exhibit 21.1

SUBSIDIARIES OF REGISTRANT

The following is a list of the Corporation’s subsidiaries as of December 31, 2010. The Corporation owns, directly or indirectly, 100% of the voting securities of each subsidiary, unless noted otherwise.

 

NAME

   

STATE OR JURISDICTION

OF ORGANIZATION

Pro-Pharmaceuticals Securities Corp.

    Delaware

Medi-Pharmaceuticals, Inc.

    Nevada

Stock widget

Investing forum

GALECTIN THERAPEUTICS INC Reports